Vaxcyte, Inc. (PCVX) › Operating Cash FlowVaxcyte, Inc. (PCVX) — Operating Cash FlowAnnual figures by fiscal year, from SEC filings.2018: -$30.47M2019: -$47.15M2020: -$46.63M2021: -$121.39M2022: -$170.60M2023: -$296.79M2024: -$452.63M2025: -$655.58M-$655.58M2018Operating Cash Flow (USD)2025Fiscal YearOperating Cash FlowChange YoY2025-$655.58M-44.8%2024-$452.63M-52.5%2023-$296.79M-74.0%2022-$170.60M-40.5%2021-$121.39M-160.3%2020-$46.63M+1.1%2019-$47.15M-54.7%2018-$30.47M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per Share